Citing the devastating emotional and economic toll that Alzheimer's disease takes on more than five million Americans and their families, Senator Collins, along with Senator Amy Klobuchar of Minnesota, introduced a bipartisan Senate Resolution declaring that the goal of preventing and effectively treating Alzheimer's by 2025 is an "urgent national priority."
Consider the following:
The resolution, which was introduced during Alzheimer's Disease Awareness Month, recognizes that dramatic increases in research funding are necessary to meet the 2025 goal and urges Congress to double the amount of funding the United States spends on Alzheimer's research in 2015, as well as develop a plan to meet the target of $2 billion a year as recommended by the experts of the federal Alzheimer's Advisory Council.
Watch Senator Collins' speech from the Senate floor:
(Click the play button above to view the video)
The resolution has been endorsed by the Alzheimer's Association and USAgainstAlzheimer's, two leading national advocacy groups.
(Click the letters above to read them) The Alzheimer's Association, Maine Chapter also applauded Senator Collins' efforts:"The Alzheimer's Association, Maine Chapter is so appreciative of Senator Collins for her leadership on this issue. We estimate that more than 37,000 Maine families are living with this devastating disease and that, as the baby boomer generation in Maine continues to age, thousands more families will face it in the coming years," said Executive Director Laurie Trenholm. "Senator Collins recognizes that this is a critical issue for the people of Maine and this country. We strongly support her resolution to increase funding for research as it represents a commitment to our vision of a world without Alzheimer's disease. There are countless volunteer advocates here in Maine who are working alongside the Senator towards this vision and we are so proud that Maine is leading this fight."
OFFICE OF SENATOR SUSAN COLLINS
413 Dirksen Senate Office Building
Washington, D.C. 20510
Phone: (202) 224-2523
Fax: (202) 224-2693
To UNSUBSCRIBE, please click here